Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Ceapro, SA's STRONG BUY and DTEA's Cream of Earl Grey

<< Previous

Bullboard Posts

Next >>

Comment by Ciaoon Apr 13, 2021 7:16am

132 Views

Post# 32983444

RE:Ceapro, SA's STRONG BUY and DTEA's Cream of Earl Grey

Good point, perhaps he will be updating his recommendation after year end results in combination with the results of the completed work with UofA.

The snippet from Seeking Alpha:

Value Investor's Stock Club by The Value Digger - OTCQX:CRPOF: It's not easy to choose only one of my ideas, but if I could invest in only one ticker for 2021, this would be Ceapro Inc. (OTCQX:CRPOF). CRPOF is an undiscovered Canadian company that also trades on Canadian Venture Exchange under the ticker CZO. CRPOF has a pristine balance sheet with profits, zero debt and low key metrics. Specifically, CRPOF trades less than 10 times its 2020 EBITDA. CRPOF could outperform this year because it's working on the production of yeast beta glucan as a potential inhalable therapeutic for COVID-19.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver